A. Tagliabue

发表

D. Boraschi, A. Tagliabue, 2006, Vitamins and hormones.

Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.

P. Bossù, F. Frigerio, G. Grandi, 1997, Journal of immunology.

Binding and internalization of the 163-171 fragment of human IL-1 beta.

G. Scapigliati, D. Boraschi, A. Tagliabue, 1992, Cytokine.

Structure-function relationship of interleukin-1 giving new insights for its therapeutic potential

D. Boraschi, A. Tagliabue, 1989, Biotherapy.

Heliodorus’s Aethiopica and the Odyssean Mnesterophonia: An Intermedial Reading

A. Tagliabue, 2015, TAPA.

Natural killer activity of gut mucosal lymphoid cells in mice

W. Luini, D. Boraschi, A. Tagliabue, 1981, European journal of immunology.

In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii

P. Bossù, L. Hammarström, G. Pozzi, 2003, BMC biotechnology.

Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors

Qin Cao, V. Bronte, A. Tagliabue, 2022, Journal of immunology research.

Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones.

R. Rappuoli, D. O'Sullivan, J. Oksenberg, 1992, Proceedings of the National Academy of Sciences of the United States of America.

The Interleukin-1 System: Physiopathology and New Insights for its Therapeutical Potential

P. Bossù, G. Scapigliati, D. Boraschi, 1992 .

Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria

J. Bienenstock, A. Tagliabue, D. Clark, 1982, The Journal of experimental medicine.

Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA

L. Nencioni, D. Boraschi, L. Villa, 1983, Nature.

IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells.

L. Nencioni, R. Rappuoli, D. Boraschi, 1984, Journal of immunology.

Radiation protection and restoration by the synthetic 163-171 nonapeptide of human interleukin 1 beta.

D. Frasca, G. Doria, D. Boraschi, 1991, Radiation research.

Interferons inhibit LTC4 production in murine macrophages.

D. Boraschi, A. Tagliabue, S. Censini, 1987, Journal of immunology.

INNAMORA, a European Workshop focussed on the mechanisms of innate immunity in pathogen–host interaction and their exploitation in novel mucosal immunisation strategies

R. Rappuoli, Michael U. Martin, D. Boraschi, 2003, Vaccine.

In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment

L. Leite, D. Boraschi, A. Tagliabue, 2019, Front. Immunol..

Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons.

D. Boraschi, A. Tagliabue, S. Censini, 1985, Journal of immunology.

Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.

D. Boraschi, A. Tagliabue, S. Censini, 1984, Journal of immunology.

Changes underway in Italy.

D. Boraschi, A. Tagliabue, P. Neri, 1984, Immunology today.

Interaction between interleukin-1 and ciliary neurotrophic factor in the regulation of neuroblastoma cell functions.

P. Bossù, D. Neumann, D. Boraschi, 1997, European cytokine network.

IFN-beta-induced reduction of superoxide anion generation by macrophages.

P. Ghezzi, M. Salmona, D. Boraschi, 1982, Immunology.

Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map

R. Rappuoli, A. Tagliabue, M. Romano, 1989, The Journal of experimental medicine.

Differential binding of IL‐ 1α and IL‐ 1β to receptors on B and T cells

D. Boraschi, A. Tagliabue, P. Ghiara, 1989 .

Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells.

G. Scapigliati, D. Boraschi, A. Tagliabue, 1989, FEBS letters.

Vaccine adjuvants: The dream becomes real

R. Rappuoli, A. Tagliabue, 2008, Human vaccines.

The effects of adriamycin and daunomycin on antitumoral immune effector mechanisms in an allogeneic system.

A. Mantovani, A. Vecchi, A. Tagliabue, 1976, European journal of cancer.

Effects of adriamycin and daunomycin on spleen cell populations in normal and tumor allografted mice.

A. Mantovani, A. Vecchi, A. Tagliabue, 1976, European journal of cancer.

A characterization of the immunosuppressive activity of adriamycin and daunomycin on humoral antibody production and tumor allograft rejection.

A. Mantovani, A. Vecchi, A. Tagliabue, 1976, Cancer research.

Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.

S. Uccini, E. Dejana, A. Santoni, 1990, The American journal of pathology.

Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines

P. Matricardi, L. Nencioni, R. Nisini, 1988, Infection and immunity.

Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.

R. Herberman, A. Tagliabue, J. Mccoy, 1978, Journal of immunology.

A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity.

D. Boraschi, A. Tagliabue, S. Censini, 1986, Journal of immunology.

Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis

L. Nencioni, R. Rappuoli, S. Romagnani, 1991, Infection and immunity.

Engineering bacterial toxins for the development of a new vaccine against whooping cough.

R. Rappuoli, M. Pizza, A. Tagliabue, 1989, Pharmacological research.

Dissecting human T cell responses against Bordetella species

R. Rappuoli, S. Nuti, A. Tagliabue, 1988, The Journal of experimental medicine.

Identification of subregions of Bordetella pertussis filamentous hemagglutinin that stimulate human T-cell responses

R. Rappuoli, A. Tagliabue, M. Bugnoli, 1991, Infection and immunity.

Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies.

L. Nencioni, G. Peri, D. Boraschi, 1985, Journal of immunology.

Characterization ofGenetically Inactivated Pertussis ToxinMutants: Candidates foraNewVaccine against Whooping Cough

R. Manetti, A. Tagliabue, M. Bugnoli, 1990 .

In Vivo Treatments with Cyclosporin-A: Different Effects on Cell-Mediated Immunity in Mice

L. Nencioni, S. Alberti, W. Luini, 1984 .

Cytolytic activity of circulating human monocytes on transformed and untransformed human fibroblasts

A. Mantovani, R. Herberman, A. Tagliabue, 1979, International journal of cancer.

Single-cell analysis of macrophage chemotactic protein-1-regulated cytosolic Ca2+ increase in human adherent monocytes.

A. Mantovani, P. Bossù, S. Sozzani, 1995, Blood.

Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues.

S. Uccini, A. Santoni, A. Stoppacciaro, 1989, The American journal of pathology.

Modulation of Mononuclear Phagocytes by Cancer Chemotherapeutic Agents

A. Mantovani, A. Tagliabue, A. Mantovani, 1983 .

IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine.

L. Nencioni, D. Boraschi, A. Tagliabue, 1986, Journal of immunology.

Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism.

G. Scapigliati, E. Vicenzi, M. Donati, 1984, Journal of immunology.

Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity

D. Boraschi, A. Tagliabue, D. Soldateschi, 1982, European journal of immunology.

In vitro generated mast cells express natural cytotoxicity against tumour cells.

G. Scapigliati, D. Boraschi, A. Tagliabue, 1985, Immunology.

Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice.

L. Nencioni, D. Boraschi, A. Tagliabue, 1983, Journal of immunology.

Morphological characterization of a cell population responsible for natural killer activity.

S. Alberti, W. Luini, D. Boraschi, 1981, Immunology.

Macrophages as regulators of immune responses against tumors.

J. R. Oehler, J. Djeu, R. Herberman, 1979, Advances in experimental medicine and biology.

Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages.

P. Sestini, D. Boraschi, A. Tagliabue, 1984, Clinical and experimental immunology.

THE MUCOSAL IMMUNOLOGICAL NETWORK: COMPARTMENTALIZATION OF LYMPHOCYTES, NATURAL KILLER CELLS, AND MAST CELLS *

J. Bienenstock, S. Mirski, A. Tagliabue, 1983, Annals of the New York Academy of Sciences.

Macrophages and interdigitating reticulum cells in normal human thymus and thymomas: immunoreactivity for interleukin‐1 alpha, interleukin‐1 beta and tumour necrosis factor alpha

S. Uccini, E. Rendina, E. Pescarmona, 1990, Histopathology.

Differential activity of interleukin 1α and interleukin 1β in the stimulation of the immune response in vivo

P. Bossù, P. Ghezzi, L. Nencioni, 1990 .

Functional epitope mapping of human interleukin-1 beta by surface plasmon resonance.

R. Casadei, D. Boraschi, A. Tagliabue, 1997, European cytokine network.

IgA-driven antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes.

L. Nencioni, P. Sestini, D. Boraschi, 1988, The American review of respiratory disease.

Antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes.

L. Nencioni, P. Sestini, D. Boraschi, 1987, Advances in experimental medicine and biology.

Cytokine Production (IL-1α, IL-1β, and TNFα) and Endothelial Cell Activation (ELAM-1 and HLA-DR) in Reactive Lymphadenitis, Hodgkin's Disease, and in Non-Hodgkin's Lymphomas: An Immunocytochemical Study

S. Uccini, A. Mantovani, E. Dejana, 1990 .

NATURAL ANTIBACTERIAL ACTIVITY AGAINST CORD BLOOD SaZrnoneZZa typhi IN HUMAN

S. Nuti, D. Boraschi, A. Tagliabue, 1989 .

Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation

A. Balduzzi, A. Tagliabue, P. Corti, 2002, Bone Marrow Transplantation.

Regulation of macrophage functions by interferon.

P. Ghezzi, J. Niederhuber, M. Salmona, 1982, Advances in experimental medicine and biology.

Learning from Allegorical Images in the Book of Visions of The Shepherd of Hermas

A. Tagliabue, 2017 .

Commentary on the first book of the "Ephesiaca" of Xenophon of Ephesus

A. Tagliabue, 2011 .

The Ephesiaca as a Bildungsroman

A. Tagliabue, 2012 .

Heliodorus’ Reading of Lucian’s Toxaris

A. Tagliabue, 2016 .

AN EMBODIED READING OF EPIPHANIES IN AELIUS ARISTIDES’ SACRED TALES

A. Tagliabue, 2016, Ramus.

The interleukin-1 receptor family.

D. Boraschi, A. Tagliabue, 2013, Seminars in immunology.

Natural cell-mediated immunity to mouse mammary tumor virus and its relevance to host immune defences.

A. Tagliabue, 1981, Antiviral research.

Structure-function relationship in the IL-1 family.

P. Bossù, D. Boraschi, A. Tagliabue, 1996, Frontiers in bioscience : a journal and virtual library.

Non-inflammatory peptide fragments of IL1 as safe new-generation adjuvants.

D. Boraschi, A. Tagliabue, P. Ghiara, 1992, Research in immunology.

In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta.

L. Nencioni, D. Boraschi, A. Tagliabue, 1987, Journal of immunology.

Environment-Breast Cancer Link and Community Outreach Targeted

W. Luini, G. Vito, D. Boraschi, 1994, Environmental Health Perspectives.

Effect of the age-related immune depression induced by MTV on the in vivo growth of a mammary carcinoma.

W. Luini, D. Boraschi, A. Tagliabue, 1981, British Journal of Cancer.

Interferon‐induced enhancement of macrophage‐mediated tumor cytolysis and its difference from activation by lymphokines

D. Boraschi, A. Tagliabue, 1981, European journal of immunology.

Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes.

D. Boraschi, A. Tagliabue, S. Censini, 1984, Immunobiology.

Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.

P. Ghezzi, M. Salmona, D. Boraschi, 1983, Journal of immunology.

Active fragments of IL-1: towards a dissociation of the functions?

D. Boraschi, A. Tagliabue, G. Antoni, 1987, Annales de l'Institut Pasteur. Immunology.

In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice.

P. Bossù, D. Frasca, G. Doria, 1988, Journal of immunology.

Natural cytotoxicity of mouse monocytes and macrophages.

A. Mantovani, R. Herberman, A. Tagliabue, 1979, Journal of immunology.

Purification of human recombinant interleukin 1 receptor antagonist proteins upon Bacillus subtilis sporulation.

P. Bossù, D. Boraschi, A. Tagliabue, 1997, Protein expression and purification.

Model of interaction of the IL‐1 receptor accessory protein IL‐1RAcP with the IL‐1β/IL‐1RI complex

R. Casadio, P. Bossù, E. Frigimelica, 2001, FEBS letters.

Immune response to oral Salmonella vaccines.

A. Tagliabue, 1989, Current topics in microbiology and immunology.

Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus.

D. Boraschi, A. Tagliabue, J. Mccoy, 1980, Journal of immunology.

Cellular immunity to tumor-associated antigens of transplantable mammary tumors of C3H/HeN mice.

L. Arthur, R. Herberman, A. Tagliabue, 1979, Cancer research.

Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses.

S. Alberti, W. Luini, D. Boraschi, 1981, International journal of immunopharmacology.

Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.

R. Herberman, A. Tagliabue, J. Mccoy, 1978, Cancer research.

Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease

A. Balduzzi, A. Tagliabue, E. Biagi, 2001, Bone Marrow Transplantation.

Ureteral Obstruction Following Allogeneic Bone Marrow Transplantation in Children

A. Balduzzi, A. Tagliabue, A. Rovelli, 2003, Pediatric Hematology & Oncology.

Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis

G. Guazzi, D. Boraschi, A. Tagliabue, 1990, The Italian Journal of Neurological Sciences.

Immunity against HIV/AIDS, Malaria, and Tuberculosis during Co-Infections with Neglected Infectious Diseases: Recommendations for the European Union Research Priorities

A. Thiel, F. Chiodi, U. Steinhoff, 2008, PLoS neglected tropical diseases.

Enhancement of in vivo immune response by tumor necrosis factor.

P. Ghezzi, L. Nencioni, D. Boraschi, 1987, Journal of immunology.

LARGE GRANULAR LYMPHOCYTES AS EFFECTOR CELLS OF NATURAL KILLER ACTIVITY IN THE MOUSE

S. Alberti, W. Luini, D. Boraschi, 1982 .

Effect of Corynebacterium parvum on cellular and humoral antitumoral immune effector mechanisms.

A. Mantovani, A. Vecchi, A. Tagliabue, 1976, European journal of cancer.

Changing Priorities in Vaccinology: Antibiotic Resistance Moving to the Top

R. Rappuoli, A. Tagliabue, 2018, Front. Immunol..

The immunostimulatory activity of 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazole [3,2-alpha]-benzimidazole-2-acetic acid (NSC 208828).

A. Mantovani, S. Garattini, A. Vecchi, 1978, European journal of cancer.

Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria

Diana Boraschi, Paolo Ruggiero, P. Bossù, 2004, BMC biotechnology.

Combination chemo-immunotherapy with adriamycin in experimental tumor systems.

A. Mantovani, A. Vecchi, A. Tagliabue, 1977, European journal of cancer.

Effect of immunomodulators on effector cells involved in antibody-dependent cellular cytotoxicity: Brief communication.

A. Mantovani, A. Vecchi, A. Tagliabue, 1977, Journal of the National Cancer Institute.

TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission

A. Balduzzi, A. Tagliabue, E. Biagi, 2000, Bone Marrow Transplantation.

The immunostimulatory effect of IL‐1β in vivo is blocked by antisense peptides complementary to the loop sequence 163–171

Andrew D. Miller, D. Boraschi, A. Tagliabue, 2009, FEBS letters.

Interleukin-1 and interleukin-1 fragments as vaccine adjuvants.

D. Boraschi, A. Tagliabue, 1999, Methods.

INTERLEUKIN 1 AND ITS SYNTHETIC PEPTIDE 163-171 AS VACCINE ADJUVANTS

D. Boraschi, A. Tagliabue, 1997 .

Engineering of IL-1 Antagonists

D. Boraschi, A. Tagliabue, 1994 .

Antibacterial resistance induced by recombinant interleukin 1 in myelosuppressed mice: effect of treatment schedule and correlation with colony-stimulating activity in the bloodstream.

P. Puccetti, M. Fioretti, F. Campanile, 1990, Cellular immunology.

Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.

P. Bossù, F. Frigerio, G. Grandi, 1995, Journal of immunology.

Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1 beta to recruit anti-tumor reactivity in recipient mice.

G. Forni, D. Boraschi, A. Tagliabue, 1989, Journal of immunology.

Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3

Francesco Tedesco, Barbara Bottazzi, Elisabetta Gianazza, 1997, The Journal of Biological Chemistry.

Biological role of the IL-1 receptor type II (IL-1RII) as defined by a monoclonal antibody

P. Bossù, G. Scapigliati, S. Nuti, 1991 .

Variation among mouse strains in responsiveness to migration inhibitory factor.

R. Herberman, A. Tagliabue, J. Mccoy, 1979, Cellular immunology.

Species‐restricted effects of human and mouse lymphokines on macrophages

A. Mantovani, D. Boraschi, A. Tagliabue, 1980, European journal of immunology.

A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo.

L. Nencioni, G. Scapigliati, D. Boraschi, 1989, Journal of immunology.

Cytokines as vaccine adjuvants: interleukin 1 and its synthetic peptide 163-171.

D. Boraschi, A. Tagliabue, 1993, Vaccine.

The Assessment of the Immunotoxicity of Xenobiotics Experience with Tetrachlorodibenzodioxin and Saccharin

A. Mantovani, S. Garattini, W. Luini, 1981 .

Binding of IL-1 beta to IL-1R type II at single cell level.

P. Bossù, G. Scapigliati, A. Stoppacciaro, 1991, Journal of immunology.

Mild pre-transplant cardiomyopathy may not impair long-term quality of life after bone marrow transplantation

M. Galli, A. Balduzzi, A. Tagliabue, 2000, Bone Marrow Transplantation.

Cellular immunity against Salmonella typhi after live oral vaccine.

L. Nencioni, D. Boraschi, A. Tagliabue, 1985, Advances in experimental medicine and biology.

IgA-Armed T Lymphocytes as Anti-S. Typhi Effectors in Humans

L. Nencioni, D. Boraschi, A. Tagliabue, 1988 .

Antibacterial activity of lymphocytes armed with IgA.

L. Nencioni, D. Boraschi, A. Tagliabue, 1987, Advances in experimental medicine and biology.

Cellular immunity against Salmonella typhi after live oral vaccine.

L. Nencioni, D. Boraschi, A. Tagliabue, 1985, Clinical and Experimental Immunology.

Modulation of in vitro natural cell-mediated activity against enteropathogenic bacteria by simple sugars

L. Nencioni, D. Boraschi, A. Tagliabue, 1985, Infection and immunity.

Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in mice.

L. Nencioni, D. Boraschi, A. Tagliabue, 1984, Clinical and experimental immunology.

Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity.

P. Ghezzi, L. Nencioni, M. Salmona, 1983, Immunology.

MURINE INTESTINAL EPITHELIUM AND LAMINA PROPRIA

J. Bienenstock, A. Tagliabue, D. Clark, 1982 .

Editorial: A Global Perspective on Vaccines: Priorities, Challenges and Online Information

R. Rappuoli, L. Leite, O. Leroy, 2019, Front. Immunol..

Quantitation of biologically active IL-1 by a sensitive assay based on immobilized human IL-1 receptor type II (IL-1RII).

P. Bossù, G. Scapigliati, D. Boraschi, 1991, Journal of immunological methods.

NATURAL KILLER ACTIVITY IN MAST CELL-DEFICIENT W/WV MICE

J. Bienenstock, A. Tagliabue, D. Befus, 1982 .

Interleukin 1 and its synthetic peptides as adjuvants for poorly immunogenic vaccines.

P. Bossù, L. Nencioni, A. Tagliabue, 1989, Advances in experimental medicine and biology.

Adjuvant activity of the 163-171 peptide of human IL-1 beta administered through different routes.

L. Nencioni, D. Boraschi, A. Tagliabue, 1987, Lymphokine research.

Synthesis and Biological Activity of the Immunomodulatory Site of Interleukin 1

L. Nencioni, D. Boraschi, A. Tagliabue, 1987 .

Sporulation: An alternative way to recover recombinant proteins from Bacillus subtilis

P. Bossù, D. Boraschi, A. Tagliabue, 1995, Biotechnology and bioengineering.

100 Years of BCG Immunization: Past, Present, and Future

L. Leite, D. Boraschi, A. Tagliabue, 2022, Vaccines.

RE-ENACTMENTS OF THE PROLOGUE IN CUPID'S PALACE: AN IMMERSIVE READING OF APULEIUS’ STORY OF CUPID AND PSYCHE

A. Tagliabue, 2021, The Classical Quarterly.

Endothelial cells express the interleukin-1 receptor type I.

G. Remuzzi, A. Sica, G. Scapigliati, 1991, Blood.

Natural antiviral activity of mouse macrophages against encephalomyocarditis virus.

D. Boraschi, A. Tagliabue, D. Soldateschi, 1985, Antiviral research.

Identification and synthesis of an antigenic determinant common to human chorionic somatomammotropin and human growth hormone.

L. Nencioni, M. Mariani, A. Tagliabue, 1984, Molecular immunology.

PRO cytokine strategies

D. Boraschi, A. Tagliabue, 1991 .

Xenophon’s Ephesiaca: A Paraliterary Love-Story from the Ancient World

A. Tagliabue, 2017 .

Thrason’s work in the Ephesian Artemision: An Artistic Inspiration for Xenophon of Ephesus’ Ephesiaca

A. Tagliabue, 2013, Hermes.

Aelius Aristides' Sacred Tales: A Study of the Creation of the “Narrative about Asclepius”

A. Tagliabue, 2016 .

Introduction: Narrative and Aesthetic Experience in Ancient Greece

A. Tagliabue, J. Grethlein, L. Huitink, 2019 .

The Romance between Greece and the East: The victory of Greek Ionia in Xenophon's Ephesiaca*

A. Tagliabue, 2013 .

Macrophage antitumor activity: impaired responsiveness to interferon‐γ of macrophages from genetically defective mice

D. Boraschi, A. Tagliabue, S. Censini, 1984, European journal of immunology.